Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.

Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.

Item
http://www.wikidata.org/entity/Q33948942
Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?Target therapy in metastatic pheochromocytoma: current perspectives and controversiesPharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapyCytocidal activities of topoisomerase 1 inhibitors and 5-azacytidine against pheochromocytoma/paraganglioma cells in primary human tumor cultures and mouse cell linesHigh-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paragangliomaNF-κB inhibition significantly upregulates the norepinephrine transporter system, causes apoptosis in pheochromocytoma cell lines and prevents metastasis in an animal model.Current approaches and recent developments in the management of head and neck paragangliomas.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentPhaeochromocytoma: a catecholamine and oxidative stress disorder.Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: focus on SDHB tumors.Familial pheochromocytomas and paragangliomas.Epigenetic regulation of drug processing genes.¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.
P2860

Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.

Item
http://www.wikidata.org/entity/Q33948942
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased uptake of [¹²³I]meta ...... istone deacetylase inhibitors.
@ast
Increased uptake of [¹²³I]meta ...... istone deacetylase inhibitors.
@en
type
label
Increased uptake of [¹²³I]meta ...... istone deacetylase inhibitors.
@ast
Increased uptake of [¹²³I]meta ...... istone deacetylase inhibitors.
@en
prefLabel
Increased uptake of [¹²³I]meta ...... istone deacetylase inhibitors.
@ast
Increased uptake of [¹²³I]meta ...... istone deacetylase inhibitors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Increased uptake of [¹²³I]meta ...... istone deacetylase inhibitors.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932